Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/24/2012CA2486537C 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds
04/24/2012CA2481926C Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha.4 integrins
04/24/2012CA2480113C Substituted amino isoxazoline derivatives and their use as anti-depressants
04/24/2012CA2472582C Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
04/24/2012CA2472190C Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
04/24/2012CA2471418C Method of obtaining novel lutein-based formulations
04/24/2012CA2466036C Taste masking spill-resistant formulation
04/24/2012CA2465132C Vaginally administered anti-dysrhythmic agents for treating pelvic pain
04/24/2012CA2457011C Treatment of glial tumors with glutamate antagonists
04/24/2012CA2456601C Oral dosage form comprising a therapeutic agent and an adverse-effect agent
04/24/2012CA2447376C Prebiotic and probiotic compositions and methods for their use in gut-based therapies
04/24/2012CA2439149C Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/24/2012CA2431557C Derivatives of streptogramins, their preparation and compositions containing them
04/24/2012CA2425599C Fumaric acid amides
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/24/2012CA2399459C Novel crude and crystalline forms of lercanidipine hydrochloride
04/24/2012CA2277141C Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure
04/24/2012CA2239072C Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
04/19/2012WO2012051633A1 The treatment of helminthic infections.
04/19/2012WO2012051614A2 Delivery of hydrophobic bioactive agents
04/19/2012WO2012051601A2 Heteroarylthio compounds
04/19/2012WO2012051587A1 Methods for inhibiting cell proliferation in egfr-driven cancers
04/19/2012WO2012051570A1 Methods and compositions for inhibition of polymerase
04/19/2012WO2012051559A2 Compositions and methods of treating pulmonary hypertension
04/19/2012WO2012051502A1 Methods and compositions related to neuroactive thiazoline compounds
04/19/2012WO2012051492A2 Compounds and methods for inhibiting hiv latency
04/19/2012WO2012051488A1 Pharmaceutical compositions containing a dgat1 inhibitor
04/19/2012WO2012051459A1 Nucleic acid delivery compounds
04/19/2012WO2012051458A1 Nucleic acid delivery compounds
04/19/2012WO2012051457A1 Nucleic acid delivery compounds
04/19/2012WO2012051416A1 Pharmaceutical formulation for histone deacetylase inhibitors
04/19/2012WO2012051410A2 Heteroaryls and uses thereof
04/19/2012WO2012051407A2 Molecular containers and methods of making and using same
04/19/2012WO2012051343A1 Methods and compositions for treating hemophilia b
04/19/2012WO2012051333A1 Antitussive compositions comprising memantine
04/19/2012WO2012051318A1 Sulphonamide compounds and methods of making and using same
04/19/2012WO2012051313A2 Ophthalmic formulations, methods of manufacture and methods of normalizing meibomian gland secretions
04/19/2012WO2012051296A2 Purine-based triazoles
04/19/2012WO2012051287A1 Coffee extracts as ingredients of foods, drugs, cosmetics, dietary supplements, and biologics
04/19/2012WO2012051251A1 Methods of treating giardiasis
04/19/2012WO2012051246A1 Tapentadol hydrobromide and crystalline forms thereof
04/19/2012WO2012051213A2 Therapeutic 5,6,5-tricyclic analogs
04/19/2012WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
04/19/2012WO2012051204A2 Antimicrobial formulations that aid in wound healing
04/19/2012WO2012051139A1 New uses for substituted 2-amino-thiazolones in treating alzheimer's disease
04/19/2012WO2012051126A2 Anti-inflammatory macrolides
04/19/2012WO2012051117A2 Substituted benzamides and their uses
04/19/2012WO2012051116A1 Clevidipine emulsion formulations containing antimicrobial agents
04/19/2012WO2012051107A2 Niacin formulations and methods with reduced flushing side-effect
04/19/2012WO2012051105A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same
04/19/2012WO2012051103A1 Serotonin reuptake inhibitors
04/19/2012WO2012051090A1 Salts of arylsulfonamide ccr3 antagonists
04/19/2012WO2012051050A1 Method for treating cystic fibrosis with inhaled denufosol
04/19/2012WO2012050985A1 Inhibitors of late sv40 factor (lsf) as cancer chemotherapeutics
04/19/2012WO2012050971A2 Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use
04/19/2012WO2012050945A1 Cationic dry powders
04/19/2012WO2012050922A2 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
04/19/2012WO2012050918A2 Tricyclic fused ring inhibitors of hepatitis c
04/19/2012WO2012050907A2 Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes
04/19/2012WO2012050899A1 Polymer-agent conjugates, particles, compositions, and related methods of use
04/19/2012WO2012050884A2 Cardiac glycosides are potent inhibitors of interferon-beta gene expression
04/19/2012WO2012050874A2 Targeting heme for the treatment of immune mediated inflammatory diseases
04/19/2012WO2012050868A1 Histone deacetylase (hdac) inhibitors targeting prostate tumors and methods of making and using thereof
04/19/2012WO2012050850A1 Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases
04/19/2012WO2012050831A2 Combination treatment for dermatological conditions
04/19/2012WO2012050735A1 Methods and dosage forms for the treatment of human cancers
04/19/2012WO2012050695A1 Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
04/19/2012WO2012050641A2 Use of trpa1 antagonists to prevent or treat infections caused by biological-warfare agents
04/19/2012WO2012050629A1 Metal complexes of n-heterocyclic carbenes
04/19/2012WO2012050623A2 Novel phenoxyisobutyric acid compounds and methods for synthesis
04/19/2012WO2012050611A2 Aptamers to glycoprotein vi
04/19/2012WO2012050594A1 Treatment for cocaine addiction
04/19/2012WO2012050591A1 Hydrogel formulation for dermal and ocular delivery
04/19/2012WO2012050589A1 Methods for treating hyperuricemia and related diseases
04/19/2012WO2012050539A1 Pharmaceutical composition comprising eplerenone
04/19/2012WO2012050532A1 Combination treatment of cancer
04/19/2012WO2012050517A1 Imidazole substituted pyrimidine having a high gsk3 inhibiting potency as well as pan-kinase selectivity
04/19/2012WO2012050513A1 Method for identifying a risk of cardiovascular disease by analysing oral microbiota
04/19/2012WO2012050512A1 Trpa1 receptor antagonist
04/19/2012WO2012050500A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
04/19/2012WO2012050483A1 Method for producing and using a copolymer of sodium carboxymethyl cellulose and gossypol
04/19/2012WO2012050465A1 Novel esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin - thioredoxin reductase system
04/19/2012WO2012050393A2 Novel compound of a reverse-turn mimetic and a production method and use therefor
04/19/2012WO2012050380A2 Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof
04/19/2012WO2012050370A2 Composition for preventing or treating rheumatoid arthritis containing a gamma secretase inhibitor as an active ingredient
04/19/2012WO2012050263A1 Novel method of preparing endoxifen
04/19/2012WO2012050229A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012WO2012050181A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012WO2012050159A1 Amide derivative and use thereof
04/19/2012WO2012050151A1 Acylbenzene derivative
04/19/2012WO2012050041A1 Aryloxyurea compound and pest control agent
04/19/2012WO2012049677A2 Compositions for treating psoriasis of the scalp
04/19/2012WO2012049665A1 A modified human u1snrna molecule, a gene encoding for the modified human u1snrna molecule, an expression vector including the gene, and the use thereof in gene therapy
04/19/2012WO2012049658A1 Compound inhibiting tp53inp1 activity for the treatment of prostate cancer, and its use in screening and diagnostic methods
04/19/2012WO2012049647A1 Phosphatidylcholine in the treatment ophosphatidylcholinef tumours
04/19/2012WO2012049642A1 A sieving method for cetyl myristate and/or cetyl palmitate
04/19/2012WO2012049641A1 Use of disintegrants in cetyl myristate and/or cetyl palmitate formulations
04/19/2012WO2012049640A1 Coating of cetyl myristate and/or cetyl palmitate particles
1 ... 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 ... 7860